Biomatter, a leading enzyme design company, has successfully closed a €6.5 million seed funding round jointly led by Inventure and UVC Partners. In 2019 Biomatter unveiled the first fully functional enzymes created with generative AI in Nature Machine Intelligence. This was a paramount milestone for the synthetic biology field, spawning multiple new research and development…
DetailsLithuaniaBIO and Lithuanian life science companies attended the BIO International Convention 2024, held in San Diego, USA from June 3-6. The BIO convention was a prime platform for the Lithuanian delegation to showcase our life sciences ecosystem and meet potential partners, fostering international collaboration crucial for driving innovation and growth in the biotech industry. The…
DetailsThe Summit Gene Editing: from Research to Industry organized by Caszyme and LithuaniaBIO Association together with partners took place! At the event, attendees heard a wealth of captivating presentations and success stories showcasing breakthroughs in gene editing research. Specialists from both academia and industry graced the symposium, offering valuable insights and expertise in genetic engineering.…
DetailsIn a landmark move within the European Union Horizon launch, the BIOCONNECT project has emerged as a pivotal initiative set to reinforce the Baltic biotechnology ecosystem’s impact in the EU. Led by a dynamic consortium comprising seven institutions from the Baltic (Estonia, Latvia, Lithuania) and Nordic regions (Finland), the project aims to establish an action…
DetailsOn 24-25 October, a delegation of Lithuanian companies took part in the European Forum For Industrial Biotechnology & The Bioeconomy 2023 (EFIB) in Rotterdam, the Netherlands. EFIB brings together professionals from across the value chain, including researchers, policy makers, regulators, and global organisations, to discuss advancements in industrial biotechnology and its contribution towards positioning Europe…
Details
